USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Efficiency Tools and Workflow Optimization to Drive Future Growth Potential
27-Jan-2021
North America
Tracker
K546-01-00-00-00
HC03387-NA-TC_25209
The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors’ business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing changes in the care standard. On a macro level, government policies on reimbursement and regulations tend to impact industry participants' performance if their internal teams delay the strategic actions needed to thrive in this new environment.
Frost & Sullivan has introduced the medical imaging and informatics industry semi-annual insights tracker to help clients address challenges in a competitive environment. Covering the diagnostic imaging, image-guided therapies, and imaging informatics segments, the tracker will monitor market factors and significant events and qualitatively assess their industry impact.
Research Highlights
Clinical Trends:
- Disruptive trends impacting the current gold standard
- Trends indicating the clinical adoption of new solutions/products
- Essential announcements from associations, such as the Radiological Society of North America (RSNA), European Society of Radiology (ESR), American College of Radiology (ACR), and American College of Cardiology (ACC)
Competition:
- New product launches and capabilities
- Mergers and acquisitions
- United States Food and Drug Administration (USFDA) and Conformité Européenne (CE) approvals
- Prominent FDA and CE recalls/warnings
Policies and Regulations:
- Introduction of region-specific regulatory approvals
- Reimbursement achievements or setbacks
Event Highlights:
- Major events highlights, covering significant themes derived by studying the messaging and communications, product launches, and product promotions at the event
Author: Suresh Kuppuswamy
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Global Medical Imaging and Informatics Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Medical Imaging and Informatics Industry Scope of Analysis
Study Indicators—Medical Imaging and Informatics Industry
Executive Summary—Medical Imaging and Informatics Industry
Long-Term Contracts (Customer Acquisitions)—Medical Imaging and Informatics Industry
Long-Term Contracts (Customer Acquisitions)—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)
Mergers and Acquisitions—Medical Imaging and Informatics Industry
Mergers and Acquisitions—Medical Imaging and Informatics Industry (continued)
Mergers and Acquisitions—Medical Imaging and Informatics Industry (continued)
Strategic Partnerships—Medical Imaging and Informatics Industry
Strategic Partnerships—Medical Imaging and Informatics Industry (continued)
Strategic Partnerships—Medical Imaging and Informatics Industry (continued)
Strategic Partnerships—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (MRI)—Medical Imaging and Informatics Industry
USFDA Approvals (CT)—Medical Imaging and Informatics Industry
USFDA Approvals (Ultrasound)—Medical Imaging and Informatics Industry
USFDA Approvals (Ultrasound)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Molecular Imaging)—Medical Imaging and Informatics Industry
USFDA Approvals (Fluoroscopy)—Medical Imaging and Informatics Industry
USFDA Approvals (X-Ray)—Medical Imaging and Informatics Industry
USFDA Approvals (X-Ray)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Breast Imaging)—Medical Imaging and Informatics Industry
USFDA Approvals (Therapy)—Medical Imaging and Informatics Industry
USFDA Approvals (Software)—Medical Imaging and Informatics Industry
USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)
USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Clinical Trends—Medical Imaging and Informatics Industry (continued)
Policies and Regulations (US)—Medical Imaging and Informatics Industry
Policies and Regulations (US)—Medical Imaging and Informatics Industry (continued)
Policies and Regulations (US)—Medical Imaging and Informatics Industry (continued)
Policies and Regulations (Australia)—Medical Imaging and Informatics Industry
Policies and Regulations (Europe)—Medical Imaging and Informatics Industry
Trending Themes at HIMSS 2020—Medical Imaging and Informatics Industry
Vendor Highlights at HIMSS 2020—Medical Imaging and Informatics Industry
Vendor Highlights at HIMSS 2020—Medical Imaging and Informatics Industry (continued)
Vendor Highlights at American College of Cardiology 2020—Medical Imaging and Informatics Industry
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Research Highlights
Clinical Trends:
- Disruptive trends impacting the current gold standard
- Trends indicating the clinical adoption of new solutions/products
- Essential announcements from associations, such as the Radiological Society of North America (RSNA), European Society of Radiology (ESR), American College of Radiology (ACR), and American College of Cardiology (ACC)
Competition:
- New product launches and capabilities
- Mergers and acquisitions
- United States Food and Drug Administration (USFDA) and Conformité Européenne (CE) approvals
- Prominent FDA and CE recalls/warnings
Policies and Regulations:
- Introduction of region-specific regulatory approvals
- Reimbursement achievements or setbacks
Event Highlights:
- Major events highlights, covering significant themes derived by studying the messaging and communications, product launches, and product promotions at the event
Author: Suresh Kuppuswamy
| Deliverable Type | Tracker |
|---|---|
| No Index | No |
| Podcast | No |
| Predecessor | MF08-01-00-00-00 |
| Author | Suresh Kuppuswamy |
| Industries | Healthcare |
| WIP Number | K546-01-00-00-00 |
| Keyword 1 | artificial intelligence in medicine |
| Keyword 2 | Medical Imaging |
| Keyword 3 | artificial intelligence research |
| Is Prebook | No |
| GPS Codes | 9600-B1,9566-B1,9570-B1,99BE-B1,9614-B1 |